Bipyrazole Derivatives as Jak Inhibitors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 7 of these applications claim priority to application 61/824,683, filed May 17, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,926,301 | Bipyrazole Derivatives as Jak Inhibitors In force · Low confidence UsedRemaining | Incyte Corporation | In force | Low confidence | ||
| US 10,435,392 | Bipyrazole Derivatives as Jak Inhibitors In force · High confidence | Incyte Corporation | In force | High confidence | ||
| US 11,001,571 | Bipyrazole Derivatives as Jak Inhibitors In force · High confidence | Incyte Corporation | In force | High confidence | ||
| US 11,591,318 | Bipyrazole Derivatives as Jak Inhibitors In force · High confidence | Incyte Corporation | In force | High confidence | ||
| US 11,905,275 | Bipyrazole Derivatives as Jak Inhibitors In force · High confidence | Incyte Holdings Corporation | In force | High confidence | ||
| US 12,247,020 | Bipyrazole Derivatives as Jak Inhibitors In force · High confidence | Incyte Corporation | In force | High confidence | ||
| US 9,382,231 | Bipyrazole Derivatives as Jak Inhibitors In force · High confidence | Incyte Corporation | In force | High confidence | ||
| Application 19/045,868 | Bipyrazole Derivatives as Jak Inhibitors Pending Not granted | Incyte Corporation | Pending | Not granted |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
7 of these are in force and held by Incyte Corporation.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.